✦ LIBER ✦

New drugs for neglected infectious diseases: Chagas' disease

✍ Scribed by Fabiana S Machado; Herbert B Tanowitz; Mauro M Teixeira

Book ID: 111219554
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 117 KB
Volume: 160
Category: Article
ISSN: 0007-1188
DOI: 10.1111/j.1476-5381.2010.00662.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Opening Opportunities for New Drugs Agai

Opening Opportunities for New Drugs Against Neglected Diseases

✍ Maria Paola Costi; Donatella Taramelli; Dolores González-Pacanowska 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Editorial: Developing drugs for neglecte

Editorial: Developing drugs for neglected diseases

✍ N. J. White 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 39 KB

Dendrimers—revolutionary drugs for infec

Dendrimers—revolutionary drugs for infectious diseases

✍ Joanna Lazniewska; Katarzyna Milowska; Teresa Gabryelak 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 840 KB

Campaigning for Chagas disease

✍ Petherick, Anna 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 459 KB

Infectious disease: Faster drugs for unk

Infectious disease: Faster drugs for unknown bugs

✍ Flemming, Alexandra 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 443 KB

Orphan drug legislation: lessons for neg

Orphan drug legislation: lessons for neglected tropical diseases

✍ Stefano Villa; Amelia Compagni; Michael R. Reich 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract In the last 20 years, orphan drug legislation (ODL) has been adopted in several countries around the world (USA, Japan, Australia, and the European Union) and has successfully promoted R&D investments to develop new pharmaceutical products for the treatment of rare diseases. Without the